BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 25617172)

  • 1. Parathyroid hormone therapy for hypoparathyroidism.
    Cusano NE; Rubin MR; Bilezikian JP
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):47-55. PubMed ID: 25617172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Hypoparathyroidism: Present and Future.
    Bilezikian JP; Brandi ML; Cusano NE; Mannstadt M; Rejnmark L; Rizzoli R; Rubin MR; Winer KK; Liberman UA; Potts JT
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2313-24. PubMed ID: 26938200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of parathyroid hormone in hypoparathyroidism.
    Cusano NE; Rubin MR; Irani D; Sliney J; Bilezikian JP
    J Endocrinol Invest; 2013 Dec; 36(11):1121-7. PubMed ID: 24445125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mini-review: new therapeutic options in hypoparathyroidism.
    Cusano NE; Rubin MR; Sliney J; Bilezikian JP
    Endocrine; 2012 Jun; 41(3):410-4. PubMed ID: 22311174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTH(1-84) replacement therapy for the treatment of hypoparathyroidism.
    Cusano NE; Rubin MR; Bilezikian JP
    Expert Rev Endocrinol Metab; 2015 Jan; 10(1):5-13. PubMed ID: 25705243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative hypoparathyroidism: medical and surgical therapeutic options.
    Walker Harris V; Jan De Beur S
    Thyroid; 2009 Sep; 19(9):967-73. PubMed ID: 19731978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTH treatment in hypoparathyroidism.
    Sikjaer T; Rejnmark L; Mosekilde L
    Curr Drug Saf; 2011 Apr; 6(2):89-99. PubMed ID: 21524246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism.
    Marcucci G; Della Pepa G; Brandi ML
    Expert Opin Drug Saf; 2017 May; 16(5):617-625. PubMed ID: 28332412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
    Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Life in Hypoparathyroidism.
    Vokes TJ
    Endocrinol Metab Clin North Am; 2018 Dec; 47(4):855-864. PubMed ID: 30390818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid Hormone Replacement Therapy in Hypoparathyroidism: A Meta-Analysis.
    Liu XX; Zhu XY; Mei GH
    Horm Metab Res; 2016 Jun; 48(6):377-83. PubMed ID: 27254756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement.
    Rubin MR; Bilezikian JP
    Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):220-6. PubMed ID: 20485912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoparathyroidism - disease update and emerging treatments.
    Monis EL; Mannstadt M
    Ann Endocrinol (Paris); 2015 May; 76(2):84-8. PubMed ID: 25882889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoparathyroidism.
    Al-Azem H; Khan AA
    Best Pract Res Clin Endocrinol Metab; 2012 Aug; 26(4):517-22. PubMed ID: 22863393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recombinant human parathyroid hormone in the therapy of hypoparathyroidism].
    Eremkina AK; Mokrysheva NG; Kovaleva EV; Krupinova YA
    Ter Arkh; 2017; 89(10):80-86. PubMed ID: 29171476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human parathyroid hormone (1-84) replacement therapy in a child with hypoparathyroidism.
    Laurer E; Grünberger J; Naidoo U; Lanzersdorfer R; Wimleitner M; Tischlinger K; Högler W
    Bone; 2021 Mar; 144():115834. PubMed ID: 33359892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of hypoparathyroidism with intact parathyroid hormone.
    Rubin MR; Sliney J; McMahon DJ; Silverberg SJ; Bilezikian JP
    Osteoporos Int; 2010 Nov; 21(11):1927-34. PubMed ID: 20094706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.
    Sikjaer T; Amstrup AK; Rolighed L; Kjaer SG; Mosekilde L; Rejnmark L
    J Bone Miner Res; 2013 Oct; 28(10):2232-43. PubMed ID: 23649554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.
    Kim ES; Keating GM
    Drugs; 2015 Jul; 75(11):1293-303. PubMed ID: 26177893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.